Potential life-years gained over a 5-year period by correcting DOPPS-identified modifiable practices in haemodialysis: results from the European MONITOR-CKD5 study

Table 3 Haemodialysis prevalent and incident counts

Countries	Source	Year of Data	HD Prevalent Count	HD Incident Count	Extrapolation to 2017
Countries	Source	Year of Data	HD Prevalent Count	HD Incident Count	HD Prevalent Count	HD Incident Count
Austria	ERA-EDTA Registry 2014¹	2014	3973	814	4599.24	942.31
France °	ERA-EDTA Registry 2014¹	2014	41,314	8321	47,826.12	9632.60
Germany	Nierenersatztherapie in Deutschland 2006–2007²	2006	63,413	16,260	108,457.11	27,809.96
Italy	Registro Italiano di Dialisi e Trapianto Report 2011–2013³	2013	41,006	8241	49,843.22	10,017.40
Poland †	ERA-EDTA Registry 2014¹ (Section B, aggregated data)⁴	2014	19,345	3954	22,394.26	4577.25
Romania ^	ERA-EDTA Registry 2014¹	2014	14,686	2538	17,000.88	2938.05
Slovenia ††	ERA-EDTA Registry 2013⁵	2013	1349	209	1639.72	254.04
Spain ~	ERA-EDTA Registry 2014¹	2014	21,517	4236	24,908.62	4903.70
Switzerland	ERA-EDTA Registry 2014¹ (Section B, aggregated data)	2014	2636	663	3051.50	767.51
United Kingdom, England only ° *	ERA-EDTA Registry 2014¹	2014	20,556	4107	23,796.14	4754.37

° Incident counts are estimated (see ERA-EDTA Registry: Annual Report 2014 for methods[22])
† Incidence data for Poland not reported; incident count imputed
^ Overall prevalence of RRT is underestimated by approximately 3% due to an estimated 30% underreporting of patients living on a functioning graft
†† Slovenia not included in ERA-EDTA Registry 2014, so 2013 ERA-EDTA data used[23]

~ Counts for Spain are sums of the following:

* Patients younger than 20 years of age are not reported
¹ ERA-EDTA Registry: Annual Report 2014 [Ref 22]
² Computed from 2006 dialysis prevalence (808 pmp X 95.2%HD) and incidence (213 pmp X 92.6%HD) rates from Nierenersatztherapie in Deutschland: Bericht über Dialysebehandlung und Nierentransplantation in Deutschland 2006-2007 [Ref 24] and 2006 population data (82,437,995) from Eurostat (http://ec.europa.eu/eurostat/)
³ Computed from 2013 dialysis prevalence (760 pmp X 90.4%HD) and incidence (160 pmp X 86.3%HD) rates from Registro Italiano Dialisi e Trapianto: Report 2011-2013 [Ref 25] and 2013 population data (59,685,227) from Eurostat (http://ec.europa.eu/eurostat/)
⁴ Prevalent count from ERA-EDTA Registry 2014¹ (Section B, aggregated data), incidence not reported; incident count imputed as Poland's HD prevalent count [19,345] X average percentage of HD incident count/HD prevalent count of 9 countries with complete data [0.2044]
⁵ ERA-EDTA Registry: Annual Report 2013 [Ref 23]

* Patients younger than 20 years of age are not reported
¹ ERA-EDTA Registry: Annual Report 2014 [22]
² Computed from 2006 dialysis prevalence (808 pmp X 95.2%HD) and incidence (213 pmp X 92.6%HD) rates from Nierenersatztherapie in Deutschland: Bericht über Dialysebehandlung und Nierentransplantation in Deutschland 2006–2007 [24] and 2006 population data (82,437,995) from Eurostat (http://ec.europa.eu/eurostat/)
³ Computed from 2013 dialysis prevalence (760 pmp X 90.4%HD) and incidence (160 pmp X 86.3%HD) rates from Registro Italiano Dialisi e Trapianto: Report 2011–2013 [25] and 2013 population data (59,685,227) from Eurostat (http://ec.europa.eu/eurostat/)
⁴ Prevalent count from ERA-EDTA Registry 2014¹ (Section B, aggregated data), incidence not reported; incident count imputed as Poland’s HD prevalent count [19,345] X average percentage of HD incident count/HD prevalent count of 9 countries with complete data [0.2044]
⁵ ERA-EDTA Registry: Annual Report 2013 [23]

ISSN: 1471-2369